Ayon, Salve S.
HRN: 21-40-64 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
06/28/2023
07/05/2023
IV
500mg
OD
CUTI; Pancreatic Cyst
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes